Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
218.9 USD | +0.64% | +0.98% | +3.94% |
Mar. 18 | Cryptocurrencies Struggle to Halt Declines as Spot ETFs See Some Slowing Inflows | MT |
Mar. 14 | Hot Producer Price Inflation Pushes US Equity Indexes Lower | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- With a 2024 P/E ratio at 23.48 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.94% | 78.3B | B | ||
+14.24% | 22.16B | C+ | ||
+37.08% | 13.64B | C+ | ||
+41.86% | 8.71B | C+ | ||
+7.13% | 8.59B | B- | ||
-8.36% | 3.4B | C | ||
-4.32% | 2.87B | C+ | ||
-0.15% | 2B | C | ||
-18.78% | 1.47B | C | ||
+22.62% | 1.38B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock CME Group Inc. - Nasdaq
- Ratings CME Group Inc.